BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18226134)

  • 1. Effect of vaginal pH on the efficacy of vaginal misoprostol for induction of midtrimester abortion.
    Abd-El-Maeboud KH; Ghazy AA; Nadeem AA; Al-Sharaky A; Khalil AE
    J Obstet Gynaecol Res; 2008 Feb; 34(1):78-84. PubMed ID: 18226134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination.
    Bhattacharjee N; Saha SP; Ganguly RP; Patra KK; Jha T; Barui G; Saha M
    Arch Gynecol Obstet; 2012 Feb; 285(2):311-6. PubMed ID: 21735193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    Contraception; 2006 Oct; 74(4):324-7. PubMed ID: 16982234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with misoprostol in the management of missed abortion in the second trimester.
    Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
    J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of labor.
    Gunalp S; Bildirici I
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):283-5. PubMed ID: 10746843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.